NCT04033367 SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" Status COMPLETED Phase PHASE4
NCT04000282 First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT03996291 Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT03994575 North American Acute Coronary Syndrome (ACS) Reflective III Pilot Status COMPLETED Phase N/A
NCT03992417 Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03989115 Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC Status COMPLETED Phase PHASE1/PHASE2
NCT03936335 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) Status RECRUITING Phase N/A
NCT03930732 Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation Status COMPLETED Phase PHASE3
NCT03916601 Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03912259 Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03909451 Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT03903016 A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT03889639 Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT03884842 Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma. Status COMPLETED Phase PHASE3
NCT03874715 Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Status COMPLETED Phase PHASE3
NCT03871348 A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03860844 Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Status TERMINATED Phase PHASE2
NCT03856619 To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE4